Platelet indices in stable chronic obstructive pulmonary disease – association with inflammatory markers, comorbidities and therapy

Autor: Andrea Vukić Dugac, Dunja Rogić, Lada Rumora, Tihana Žanić Grubišić, Sanja Popović-Grle, Iva Hlapčić, Anita Somborac-Bačura, Ivana Rako
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
Lymphocyte
blood platelets
Clinical Biochemistry
030204 cardiovascular system & hematology
Fibrinogen
Gastroenterology
BIOMEDICINE AND HEALTHCARE. Pharmacy. Medical Biochemistry
Pulmonary Disease
Chronic Obstructive

0302 clinical medicine
Adrenal Cortex Hormones
Forced Expiratory Volume
Leukocytes
Platelet
BIOMEDICINA I ZDRAVSTVO. Farmacija. Medicinska biokemija
Lymphocytes
Aged
80 and over

COPD
medicine.diagnostic_test
Platelet Distribution Width
Complete blood count
Middle Aged
medicine.anatomical_structure
Cardiovascular Diseases
Female
medicine.drug
Blood Platelets
medicine.medical_specialty
chronic obstructive pulmonary disease
03 medical and health sciences
inflammation
therapy
Metabolic Diseases
Internal medicine
medicine
Humans
Mean platelet volume
Adrenergic beta-2 Receptor Agonists
Aged
Lung
business.industry
Biochemistry (medical)
Original Articles
medicine.disease
Logistic Models
030228 respiratory system
Case-Control Studies
business
Biomarkers
Zdroj: Biochemia Medica
Volume 30
Issue 1
ISSN: 1330-0962
1846-7482
Popis: Chronic obstructive pulmonary disease (COPD) is a complex inflammatory condition that can affect haemostasis. This study aimed to determine differences in platelet-related parameters between controls and COPD subjects. The hypothesis was that platelet indices are disturbed in COPD patients, and this would be accompanied by increased C-reactive protein (CRP), fibrinogen (Fbg) and white blood cells (WBC). Therefore, platelet count (Plt), platelet-related parameters – mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit (Pct), their ratios (MPV/Plt, MPV/Pct, PDW/Plt, PDW/Pct), platelet to lymphocyte ratio (PLR), Plt index as well as CRP, Fbg and WBC were assessed. Materials and methods: Study included 109 patients with stable COPD and 95 control subjects, recruited at Clinical Department for Lung Diseases Jordanovac, University Hospital Centre Zagreb (Zagreb, Croatia). Complete blood count was performed on Sysmex XN-1000, CRP on Cobas c501, and Fbg on BCS XP analyser. Data were analysed with MedCalc statistical software. Results: Platelet (P = 0.007) and PLR (P = 0.006) were increased, while other platelet indices were decreased in COPD patients compared to controls. Combined model that included PLR, PDW and WBC showed great diagnostic performances, and correctly classified 75% of cases with an AUC of 0.845 (0.788 – 0.892), P < 0.001. Comorbidities (cardiovascular or metabolic diseases) had no effect on investigated parameters, while inhaled corticosteroids/long-acting β2-agonists (ICS/LABA) therapy increased MPV and PDW values in COPD patients. Conclusion: Platelet indices were altered in COPD patients and they could be valuable as diagnostic markers of COPD development, especially if combined with already known inflammatory markers.
Databáze: OpenAIRE